Alviset, G.; Corvis, Y.; Hammad, K.; Lemut, J.; Maury, M.; Mignet, N.; Boudy, V.
New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma. Pharmaceutics 2022, 14, 453.
https://doi.org/10.3390/pharmaceutics14020453
AMA Style
Alviset G, Corvis Y, Hammad K, Lemut J, Maury M, Mignet N, Boudy V.
New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma. Pharmaceutics. 2022; 14(2):453.
https://doi.org/10.3390/pharmaceutics14020453
Chicago/Turabian Style
Alviset, Gabriel, Yohann Corvis, Karim Hammad, Josiane Lemut, Marc Maury, Nathalie Mignet, and Vincent Boudy.
2022. "New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma" Pharmaceutics 14, no. 2: 453.
https://doi.org/10.3390/pharmaceutics14020453
APA Style
Alviset, G., Corvis, Y., Hammad, K., Lemut, J., Maury, M., Mignet, N., & Boudy, V.
(2022). New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma. Pharmaceutics, 14(2), 453.
https://doi.org/10.3390/pharmaceutics14020453